In regard to MDSCs, FAP+ CAFs releasing CCL2 is recognized by the CCL2 receptor that expressed on circulating MDSCs, leading to the poly-morphonuclear MDSCs infiltration or circulating MDSCs recruitment into the tumor microenvironment [48–50]. The gene discussed is CCL2; the disease is neoplasm.